173 related articles for article (PubMed ID: 11229607)
1. Glucose degradation products and the peritoneal mesothelium.
Jörres A; Bender TO; Witowski J
Perit Dial Int; 2000; 20 Suppl 5():S19-22. PubMed ID: 11229607
[TBL] [Abstract][Full Text] [Related]
2. First in vitro and in vivo experiences with Stay-Safe Balance, a pH-neutral solution in a dual-chambered bag.
Lage C; Pischetsrieder M; Aufricht C; Jörres A; Schilling H; Passlick-Deetjen J
Perit Dial Int; 2000; 20 Suppl 5():S28-32. PubMed ID: 11229609
[TBL] [Abstract][Full Text] [Related]
3. Biological significance of reducing glucose degradation products in peritoneal dialysis fluids.
Wieslander A; Linden T; Musi B; Carlsson O; Deppisch R
Perit Dial Int; 2000; 20 Suppl 5():S23-7. PubMed ID: 11229608
[TBL] [Abstract][Full Text] [Related]
4. Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation.
Ha H; Yu MR; Choi HN; Cha MK; Kang HS; Kim MH; Lee HB
Perit Dial Int; 2000; 20 Suppl 5():S10-8. PubMed ID: 11229606
[TBL] [Abstract][Full Text] [Related]
5. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids.
Schalkwijk CG; Posthuma N; ten Brink HJ; ter Wee PM; Teerlink T
Perit Dial Int; 1999; 19(4):325-33. PubMed ID: 10507813
[TBL] [Abstract][Full Text] [Related]
6. Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: a study of residual fluid and mesothelial cells.
Linden T; Musi B; Järkelid L; Forsbäck G; Kjellstrand P; Deppisch R; Wieslander A
Perit Dial Int; 2001; 21(6):607-10. PubMed ID: 11783771
[TBL] [Abstract][Full Text] [Related]
7. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
Park MS; Kim JK; Holmes C; Weiss MF
Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
[TBL] [Abstract][Full Text] [Related]
8. Structure- and concentration-specific assessment of the physiological reactivity of α-dicarbonyl glucose degradation products in peritoneal dialysis fluids.
Distler L; Georgieva A; Kenkel I; Huppert J; Pischetsrieder M
Chem Res Toxicol; 2014 Aug; 27(8):1421-30. PubMed ID: 25033248
[TBL] [Abstract][Full Text] [Related]
9. Glucose degradation products and peritoneal membrane function.
Witowski J; Bender TO; Gahl GM; Frei U; Jörres A
Perit Dial Int; 2001; 21(2):201-5. PubMed ID: 11330569
[TBL] [Abstract][Full Text] [Related]
10. Glucose degradation products increase apoptosis of human mesothelial cells.
Amore A; Cappelli G; Cirina P; Conti G; Gambaruto C; Silvestro L; Coppo R
Nephrol Dial Transplant; 2003 Apr; 18(4):677-88. PubMed ID: 12637635
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.
Lai KN; Leung JC; Chan LY; Li FF; Tang SC; Lam MF; Tse KC; Yip TP; Chan TM; Wieslander A; Vlassara H
Clin Exp Immunol; 2004 Dec; 138(3):466-75. PubMed ID: 15544624
[TBL] [Abstract][Full Text] [Related]
12. Chemical and physiological relevance of glucose degradation products in peritoneal dialysis.
Mittelmaier S; Niwa T; Pischetsrieder M
J Ren Nutr; 2012 Jan; 22(1):181-5. PubMed ID: 22200439
[TBL] [Abstract][Full Text] [Related]
13. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
[TBL] [Abstract][Full Text] [Related]
14. Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro?
Wieslander AP; Andrén AH; Nilsson-Thorell C; Muscalu N; Kjellstrand PT; Rippe B
Perit Dial Int; 1995; 15(8):348-52. PubMed ID: 8785233
[TBL] [Abstract][Full Text] [Related]
15. Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.
Sundaram S; Cendoroglo M; Cooker LA; Jaber BL; Faict D; Holmes CJ; Pereira BJ
Am J Kidney Dis; 1997 Nov; 30(5):680-9. PubMed ID: 9370184
[TBL] [Abstract][Full Text] [Related]
16. [Biocompatibility of peritoneal dialysis fluids].
Boulanger E; Moranne O; Wautier MP; Rougier JP; Ronco P; Pagniez D; Wautier JL
Nephrol Ther; 2005 Mar; 1(1):14-22. PubMed ID: 16895663
[TBL] [Abstract][Full Text] [Related]
17. Can we prevent the degradation of glucose in peritoneal dialysis solutions?
Ledebo I; Wieslander A; Kjellstrand P
Perit Dial Int; 2000; 20 Suppl 2():S48-51. PubMed ID: 10911643
[No Abstract] [Full Text] [Related]
18. Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response.
Welten AG; Schalkwijk CG; ter Wee PM; Meijer S; van den Born J; Beelen RJ
Perit Dial Int; 2003; 23(3):213-21. PubMed ID: 12938820
[TBL] [Abstract][Full Text] [Related]
19. PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization.
Erixon M; Lindén T; Kjellstrand P; Carlsson O; Ernebrant M; Forsbäck G; Wieslander A; Jönsson JA
Perit Dial Int; 2004; 24(4):392-8. PubMed ID: 15335155
[TBL] [Abstract][Full Text] [Related]
20. Heat sterilization of peritoneal dialysis solutions influences ingestive behavior in non-uremic rats.
Zheng ZH; Anderstam B; Qureshi AR; Heimbürger O; Wang T; Södersten P; Bergström J; Lindholm B
Kidney Int; 2002 Oct; 62(4):1447-53. PubMed ID: 12234318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
